Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic. - Kang MS; Shin M; Ottoy J; Aliaga AA; Mathotaarachchi S; Quispialaya K; Pascoal TA; Collins DL; Chakravarty MM; Mathieu A; Sandelius Å; Blennow K; et al. (Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022)